Gopal Kundu

Gopal Chandra Kundu (born 1959) is an renowned Indian cell and cancer biologist and a Senior Scientist (Scientist-G) at National Centre for Cell Science.[1] He is known for his contributions towards the understanding the mechanism of cancer progression in breast, melanoma and other cancers and development of novel therapeutic targets and target-based therapy in cancers.[2]

Gopal Kundu
Born (1959-11-02) 2 November 1959
Bataspur, West Bengal
NationalityIndian
Known forTherapeutics; Biomarker (cell); Angiogenesis; Nanomedicine;
AwardsN-BIOS Prize, Shanti Swarup Bhatnagar Prize for Science and Technology
Scientific career
FieldsCancer
InstitutionsNational Centre for Cell Science

An elected fellow of the Indian Academy of Sciences[3] and the National Academy of Sciences, India,[4] he received the National Bioscience Award for Career Development of the Department of Biotechnology in 2003.[5] The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2004, for his contributions to biological sciences.[6]

Education and career

Kundu obtained his Ph.D. from Bose Institute, Kolkata, India (1989) in protein biochemistry and did his post-doctoral research work at the Cleveland Clinic Foundation, University of Colorado, University of Wyoming, and the National Institutes of Health from 1989 to 1998. He has performed work in the area of cardiovascular biology, inflammation and immunomodulation during that period. In 1998, he joined as Scientist-D at the National Centre for Cell Science (NCCS), Pune.[7] At present, he is working as Scientist-G at NCCS. His area of research at NCCS is tumor biology, regulation of gene expression, cell signaling, angiogenesis, cancer therapeutics, biomarker studies for cancer detection, and nanomedicine.[8][9]

He is Fellow of The National Academy of Sciences, India, and Indian Academy of Sciences. He is member of American Society for Biochemistry and Molecular Biology and New York Academy of Sciences. He has published 70 papers in peer reviewed international journals.

He serves as Editorial Board Member of Current Molecular Medicine, Molecular Medicine Reports, The Open Cancer Journal and American Journal of Cancer Research.

Awards

In 2004 Kundu was awarded a Shanti Swarup Bhatnagar Prize for Science and Technology,[10][11] following the receipt of an earlier National Bioscience Award for Career Development in 2003.[11] International Journal of Oncology, Oncology Reports and International Journal of Molecular Medicine Award for an outstanding achievement in Oncology, Greece; International Young Investigator Award, USA. 7th National Grassroots Innovation Award-2013, Rashtrapati Bhavan, New Delhi.

Controversy

A controversy erupted in the NCCS in 2006 when an anonymous mail alleged that Kundu and others might have misrepresented data in a paper published in the Journal of Biological Chemistry. The allegation was that they had rehashed the same set of data which they had published earlier.[12] An internal committee of the NCCS advised the authors to take back their paper, however an independent committee led by G. Padmanabhan, a former director of Indian Institute of Science, Bangalore, concluded that there was no manipulation in the data.[13] This led to some heated debate between Indian Scientists with several viewpoints being presented.[14][15] On 23 February 2007, the Journal of Biological Chemistry withdrew the paper amid allegations of data manipulation, although the authors maintained that the two papers used different set of data though similar experiments. One JBC paper was retracted by JBC [16] because they found the data to be unreliable.[17] In November 2010, after an internal investigation by its ethics committee, the Indian Academy of Sciences banned Gopal Kundu from participating in its activities for three years.[18]

Selected publications
gollark: ++ping
gollark: https://discord.com/channels/346530916832903169/348702212110680064/749447573844000818
gollark: Macron is weird enough that I'd totally believe it.
gollark: In osmarkslanguage™, while the basic syntax of string literals is in the language spec and everything, and even turn up in some of the examples, they are undefined behavior.
gollark: SIGNED integer overflow.

See also

References
  1. "Brief Profile of the Awardee". Shanti Swarup Bhatnagar Prize. 2016. Retrieved 5 October 2016.
  2. "Handbook of Shanti Swarup Bhatnagar Prize Winners" (PDF). Council of Scientific and Industrial Research. 1999. p. 34. Archived from the original (PDF) on 4 March 2016. Retrieved 5 October 2016.
  3. "Fellow profile - G C Kundu". Indian Academy of Sciences. 2016. Retrieved 6 October 2016.
  4. "NASI fellows". National Academy of Sciences, India. 2016. Archived from the original on 15 March 2016. Retrieved 20 October 2016.
  5. "N-BIOS Prize" (PDF). Department of Biotechnology. 2016. Retrieved 20 October 2016.
  6. "View Bhatnagar Awardees". Shanti Swarup Bhatnagar Prize. 2016. Retrieved 5 October 2016.
  7. "Dr. Gopal Kundu". NCCS. 1 January 2001. Archived from the original on 27 September 2011. Retrieved 8 November 2011.
  8. "DBT neurobiology task force". Neurobiology. 5 March 2004.
  9. "Curriculum vitae". apoptosis. 20 August 2005. Archived from the original on 25 April 2012. Retrieved 9 November 2011.
  10. "PM presents Bhatnagar prizes to 21 scientists". The Times of India. 29 September 2005.
  11. "Two Pune scientists bag Bhatnagar prize". The Times of India. 29 September 2004.
  12. "Kundu-JBC Case". Society for Scientific Values.
  13. G.S. mudur (6 March 2007). "Indicted there, acquitted here". The Telegraph. Calcutta, India.
  14. S.P. Modak (10 June 2007). "Investigating Misconduct in Science" (PDF). Current Science. 92 (11).
  15. G. Padmanabhan (10 June 2007). "The NCCS Case" (PDF). Current Science. 92 (11).
  16. "JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation". J. Biol. Chem. 282 (8): 5968. 2007. PMID 17380579.
  17. Hema Rangaswami (12 September 2007). "'Coping with misconduct in Indian science': a response". The Hindu. Chennai, India.
  18. Jayan, T.V. (14 November 2010). "'Rehashing catches up - Once-acquitted biologist barred for 3 years'". The Telegraph. Kolkata, India.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.